| Target Price | $86.70 |
| Price | $71.42 |
| Potential | 21.39% |
| Number of Estimates | 24 |
| 24 Analysts have issued a price target GE HealthCare Technologies 2027 . The average GE HealthCare Technologies target price is $86.70. This is 21.39% higher than the current stock price. The highest price target is $100.80 41.14% , the lowest is $71.71 0.41% . | |
| A rating was issued by 28 analysts: 19 Analysts recommend GE HealthCare Technologies to buy, 9 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the GE HealthCare Technologies stock has an average upside potential 2027 of 21.39% . Most analysts recommend the GE HealthCare Technologies stock at Purchase. |
23 Analysts have issued a sales forecast GE HealthCare Technologies 2026 . The average GE HealthCare Technologies sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
18 Analysts have issued an GE HealthCare Technologies EBITDA forecast 2026. The average GE HealthCare Technologies EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
25 GE HealthCare Technologies Analysts have issued a net profit forecast 2026. The average GE HealthCare Technologies net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
25 Analysts have issued a GE HealthCare Technologies forecast for earnings per share. The average GE HealthCare Technologies EPS is
. This is than earnings per share in the financial year 2025. The highest EPS forecast is , the lowest is .This results in the following potential growth metrics and future valuations:
GE HealthCare Technologies...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BTIG |
Buy
➜
Buy
|
Unchanged | Oct 12 2026 |
| Barclays |
➜
Overweight
|
Initiated | Oct 07 2026 |
| Citigroup |
Neutral
➜
Neutral
|
Unchanged | Oct 05 2026 |
| Needham |
Buy
➜
Buy
|
Unchanged | Oct 05 2026 |
| Needham |
➜
Buy
|
Initiated | Sep 22 2026 |
| BTIG |
Buy
➜
Buy
|
Unchanged | Sep 17 2026 |
| BTIG |
Buy
➜
Buy
|
Unchanged | Aug 19 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
BTIG:
Buy
➜
Buy
|
Oct 12 2026 |
|
Initiated
Barclays:
➜
Overweight
|
Oct 07 2026 |
|
Unchanged
Citigroup:
Neutral
➜
Neutral
|
Oct 05 2026 |
|
Unchanged
Needham:
Buy
➜
Buy
|
Oct 05 2026 |
|
Initiated
Needham:
➜
Buy
|
Sep 22 2026 |
|
Unchanged
BTIG:
Buy
➜
Buy
|
Sep 17 2026 |
|
Unchanged
BTIG:
Buy
➜
Buy
|
Aug 19 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


